About
Bio-Technology General Israel (BTG) is an integrated biopharmaceutical services company that develops and manufactures healthcare products derived from genetic engineering and biotechnology processes. BTGs Biolon, first introduced in 1993, is an injectable system containing 1% fermentation-derived sodium hyaluronate (NaHA) used as a viscoelastic aid in cataract and other ophthalmic surgeries. Euflexxa is a treatment to help relieve knee pain due to osteoarthritis (OA). It is used by thousands of people to help manage OA knee pain and stay active. Containing 1% fermentation-derived sodium hyaluronate, Euflexxa is intended for intra-articular injection into the knee. Developed in the 1980s, BTGs recombinant human growth hormone (somatropin for injection or hGH) first gained regulatory approval in 1988. It is identical to natural human growth hormone synthesized by the pituitary gland, and is used to treat Turner syndrome and growth hormone deficiency in children. BTG is a wholly owned subsidiary of Ferring Pharmaceuticals.
Funding history · 4 rounds · $26.9M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was BTG acquired and by which company?
- BTG was acquired by Ferring Pharmaceuticals in January 2005.
- What is Biolon and when was it first introduced by BTG?
- Biolon is an injectable system containing 1% fermentation-derived sodium hyaluronate (NaHA) used as a viscoelastic aid in cataract and other ophthalmic surgeries. It was first introduced by BTG in 1993.
- What is Euflexxa used for?
- Euflexxa is a treatment developed by BTG to help relieve knee pain due to osteoarthritis (OA) through intra-articular injection of 1% fermentation-derived sodium hyaluronate.
- When did BTG's recombinant human growth hormone (somatropin) first receive regulatory approval?
- BTG's recombinant human growth hormone (somatropin for injection or hGH), developed in the 1980s, first gained regulatory approval in 1988.
- How many employees does BTG have?
- BTG has 348 employees.
- What was the total amount raised by BTG through funding rounds?
- BTG raised a total of $26,930,000 through its funding rounds. For a full financing history, users can refer to startupim.
- Which company invested $15 million in BTG in May 2018?
- Ferring Pharmaceuticals invested $15 million in BTG in May 2018.
- What is BTG's vision regarding Israel's role in biological GMP production, as reported in September 2023?
- According to a September 2023 report, BTG's vision is for the State of Israel to be a world leader in biological GMP production.
- When did Biotechnology General open a new production line to increase manufacturing capacity?
- Biotechnology General opened a new production line to boost manufacturing capacity in October 2019.